COVID-19 vaccine acceptance among pregnant women: a multicentre cross-sectional survey in Port Harcourt, Nigeria

¹Department of Haematology and Blood Transfusion, Rivers State University/Rivers State University Teaching Hospital, Port Harcourt, Nigeria, ²Department of Nursing Sciences, Rivers State University, Port Harcourt, Nigeria, ³Department of Obstetrics and Gynaecology, Rivers State University/Rivers State University Teaching Hospital, Port Harcourt, Nigeria, ⁴Department of Family Medicine, Rivers State University/Rivers State University Teaching Hospital. Port Harcourt, Nigeria

^&Corresponding author
Simeon Chijioke Amadi, Department of Obstetrics and Gynaecology, Rivers State University/Rivers State University Teaching Hospital, Port Harcourt, Nigeria

Introduction    

COVID-19 was declared a pandemic in March 2021 by the World Health Organization. Infection prevention modalities such as the use of facemasks, hand hygiene, and respiratory hygiene have been effective in preventing the spread of the infection, however in the last 1 year effective vaccines have been developed to prevent the infection and reduce the severity of the infection in people that are exposed. About 62% of the world´s population has been vaccinated, the majority of those vaccinated are in developed countries, and only 12% of the Nigerian population has been vaccinated at the time of this report.

According to WHO (2022), equitable access to effective and safe vaccines is critical to ending the COVID-19 pandemic. However, in addition to people being vaccinated, there is still a need to ensure good ventilation indoors, avoidance of crowds and maintaining physical distancing, wearing of masks, and performance of hand hygiene to control the spread of COVID-19 disease. Pregnancy was not found to predispose to a higher risk for COVID-19 infection as compared to non-pregnant women, however symptomatic pregnant women had more adverse outcomes than non-pregnant women [1]. COVID-19 infection is associated with high rates of preterm and cesarean births [2] as well as increased risk of fetal mortality [3]. Some studies in Nigeria have evaluated the willingness of Nigerians to receive the COVID-19 vaccine to be between 50-60% [4,5]. Many factors are linked with COVID-19 vaccine hesitancy in our society, but the myths surrounding its use in pregnancy have to do with claims that the vaccine causes infertility. This study sought to ascertain the prevalence of vaccination among pregnant women and the reasons for COVID-19 vaccine hesitancy among pregnant women in Port Harcourt.

Methods     

Study design and study setting: this was a cross-sectional prospective study conducted in the three large obstetric centers in Port Harcourt, Nigeria (Rivers State University Teaching Hospital, University of Port Harcourt Teaching Hospital, Obio-Cottage Health Centre) between January 14^th 2022 to March 18^th 2022, among pregnant women who were receiving antenatal care. The Port Harcourt is a metropolitan city in the Rivers State of Nigeria. The Rivers State is a core Niger Delta state in Nigeria. The health facilities in Port Harcourt, especially the tertiary ones, receive referrals from neighboring states. Rivers State has over five million residents and it is the sixth most populous state in Nigeria with a land mass of about 11,077 km² (4,277 square meters).

Inclusion/exclusion criteria: pregnant women attending antenatal care in the study centers were included in the study. Those who did not give consent were excluded from the study.

Data collection: six research assistants were recruited and trained for the study. The research assistants recruited the patients who met the inclusion criteria daily from the antenatal clinic. The recruited participants were counseled and informed consent was obtained. The data for this study was collected using an adapted, structured, electronic questionnaire [6-8] administered once to each participant who could fill out the form on their device. For those who consented to participate but did not have a smartphone, a trained research assistant administered the questionnaire from his tablet and assisted the participant in filling and submit. The questionnaire contained seventeen questions about the socio-demographics characteristics, educational status, obstetric history, vaccination history, knowledge of COVID-19, and willingness to receive the COVID-19 vaccination.

Sample size determination and sampling techniques: the sample size was calculated using the formula:

Where, n = minimum sample size, Z = the standard normal deviation of 95% confidence level. This corresponds to 1.96. P = prevalence of COVID-19 vaccine acceptance in the antenatal women in Nigeria from previous studies = 33.8% (0.338) [7], d = level of precision (0.05). The minimum sample size was thus calculated to be 343. Given allowance for a 10% attrition rate (non-response rate), the adjusted sample size for the study was therefore 378 women. A total of 927 consenting pregnant women were however recruited through the simple random sampling method by balloting after the selection of the health facilities using the purposive sampling method.

Statistical methods: data was collated and analyzed on a Statistical Package for Social Sciences software (SPSS) version 23. Simple proportions were used in the descriptive analysis. Quantitative data were summarized and presented as mean and standard deviation while qualitative data were presented as numbers and percentages. The Chi-square test was used to compare categorical variables with a p-value of 0.05 or less taken as being statistically significant.

Ethical approval: it was obtained from the Hospital Ethics Committee of the Rivers State University Teaching Hospital. The ethical approval number was RSUTH/REC/2022/175.

Results     

Socio-demographic characteristics: in total, we had nine hundred and twenty-seven respondents within the study period. The majority of the respondents 297 (32.3%) were 31-35 years. The majority of the respondents 556 (60%) had completed tertiary education, 891 (96.2%) were married, and 494 (53.3%) had partners with a tertiary level of education. Most of them were self-employed 587 (63.3%) and had 1-3 people in their households as shown in Table 1.

COVID-19 prevention practices carried out by respondents: majority of the respondents 814 (87.8%) used Face masks and 117 (12.6%) used hand sanitizers for the prevention of COVID-19. One person (0.1%) admitted that she did nothing to prevent COVID-19 as shown in Figure 1.

Pregnancy, antenatal care, and immunization history of respondents: twenty-seven (2.9%) of the respondents had or a close family member tested positive for COVID-19 during the pandemic, and the majority 897 (96.8%) had heard of COVID-19 vaccination. However, only 133 (14.4%) had been vaccinated against the virus. Most of the respondents had been vaccinated for Tetanus in the index pregnancy 785 (84.7%). The majority of the parous women had vaccinated their infant for childhood vaccine-preventable diseases, however, 14 (2.3%) had not vaccinated their infants in the past. Of the 927 respondents, 222 (23.9%) said they would be willing to receive the COVID-19 vaccine if it was free and commonly available in the antenatal clinic as shown in Table 2.

Reasons for not taking COVID-19 vaccine: the main reason for COVID-19 vaccine hesitancy among the respondents was the concern for the safety of the unborn baby, and so many wanted to take the vaccine after delivery as shown Table 3.

Predictors of COVID-19 vaccine uptake: on bivariate analysis, the predictors of vaccine uptake in the respondents were younger age <35 years, marital status, formal education, and having employment. However, logistic regression showed that achievement of tertiary education, use of childhood immunization for previous infants delivered, and availability of COVID-19 vaccine in the antenatal clinic at no cost were significant predictors of vaccine uptake in the respondents as shown in Table 4 and Table 4.1.

Discussion     

The COVID-19 Pandemic ravaged the world from 2019 to date and despite the approval of the COVID-19 vaccine for use even in pregnancy, there has been a global hesitancy of acceptance of the vaccine by the parturients [9,10]. In this study, the COVID-19 vaccine acceptance rate by pregnant women who had not been vaccinated was 23.9%. This is lower than findings from other studies in Ethiopia (70.9%) [11], Addis Ababa (80.9%) [12], China (91.3%) [13], Indonesia, Southeast Asia (93.3%) [14], South Africa (81.6%) [15], Saudi Arabia (64.7%) [16], United States (67%) [17], but similar to findings from the studies in Middle Eastern Populations (36.8%) [18 ], Poland (31.3%) [19], Turkey (37%) [20 ] and Kano in Nigeria (33.8%) [6]. The observed difference may be due to the differences in access to healthcare services in the different study areas, awareness of the severity of COVID-19, the number of fatalities due to COVID-19 in the different study populations, and other study population differences.

Tertiary level of education was found to be significantly associated with uptake of the COVID-19 vaccine among respondents. This is similar to the finding in a survey of 664 women in France, where higher education achievement was associated with willingness to receive the vaccine [21]. This is at variance with the findings from studies in Ethiopia and South Africa where primary level of education was found to be associated with acceptance of the COVID-19 vaccine [3,22]. The difference may be due to the variations in the availability of news and access to social media.

The reasons for the non-acceptance of the COVID-19 vaccine found in this study were safety concerns for the parturient and her unborn baby and the unavailability of the vaccine. This is like findings from other studies in Ethiopia and Northern Nigeria [3,13]. The awareness level of COVID-19 and its preventive measures among respondents in this study was high Figure 1. This is similar to the findings in the study in Ethiopia [3]. This similarity may be because the two studies were carried out among pregnant women who routinely undergo antenatal classes and have regular health enlightenment from their attending physicians and nurses on COVID-19 and other health-related issues. This finding is however, higher than findings from other studies conducted among Gondar City residents, in Northern Ethiopia (50.7%) [23], and in Dirashe district, Southern Ethiopia (63.5%) [24]. The variation may be because participants in these studies did not have as many health education opportunities as the pregnant women in our study as those studies were carried out in the general population.

The major preventive measures against COVID-19 adopted by the respondents in this study were the use of face masks and use of hand sanitizers. The adoption of preventive measures by a large percentage of the respondents in this study is higher than the results from the studies in Gondar City in Ethiopia [15] and in South Africa [25]. The differences found in these studies may be because pregnant women routinely visit the hospitals for antenatal where they are taught and mandated to adopt COVID-19 preventive measures for their safety and that of the health workers. Respondents in the other studies may not have as many opportunities for COVID-19 education and application of such knowledge as pregnant women.

Limitation: this study was carried out in an urban area in Southern Nigeria. This notwithstanding, Port Harcourt is a metropolitan city with people from different tribes and socio-economic statuses. And so, within the limits of acceptable error, the findings of this study should be reflective of the general population.

Conclusion     

In this study, the COVID-19 vaccine acceptance level among pregnant women in Port Harcourt, Nigeria was low. Tertiary level of education was found to be significantly associated with COVID-19 vaccine acceptance in pregnancy and there was high awareness of COVID-19 and its preventive measures among the parturient in this study. Safety concerns for both the mother and the baby were the main reason for the high level of COVID-19 vaccine hesitancy found in this study. Steps should be taken by the government and all stakeholders to make the COVID-19 vaccine available in routine antenatal services and educate the women and their families on the benefits, efficacy, and safety of the vaccine to improve the acceptability of the vaccine among the pregnant population in our setting.

Competing interests     

The authors declare no competing interests.

Authors' contributions     

The authors conceptualised this research as a group. They collectively collected the data. All the authors have read and agreed to the final manuscript.

Acknowledgments     

We especially acknowledge the research assistants - Bariedoora and Mary and their colleagues for their diligence.

Tables and figure     

Table 1: socio-demographic characteristics

Table 2: pregnancy, antenatal care (ANC), and immunization history of the respondent

Table 3: reasons for not taking COVID-19 vaccine

Table 4: predictors of COVID-19 vaccine uptake

Table 4.1: predictors of COVID-19 vaccine uptake

Figure 1: COVID-19 prevention practices carried out by respondents

References